I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 6 studies | 22% ± 7% | |
| glutamatergic neuron | 4 studies | 41% ± 14% | |
| GABAergic neuron | 3 studies | 40% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 6 studies | 22% ± 7% | |
| glutamatergic neuron | 4 studies | 41% ± 14% | |
| GABAergic neuron | 3 studies | 40% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 33% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 1046.51 | 2642 / 2642 | 100% | 18.21 | 705 / 705 |
| ovary | 100% | 685.79 | 180 / 180 | 100% | 7.13 | 428 / 430 |
| esophagus | 100% | 625.47 | 1445 / 1445 | 99% | 11.38 | 182 / 183 |
| prostate | 100% | 605.54 | 245 / 245 | 99% | 8.27 | 498 / 502 |
| lung | 99% | 565.75 | 574 / 578 | 100% | 11.16 | 1151 / 1155 |
| breast | 100% | 664.49 | 459 / 459 | 99% | 8.02 | 1105 / 1118 |
| thymus | 100% | 670.77 | 651 / 653 | 99% | 9.33 | 599 / 605 |
| uterus | 100% | 703.57 | 170 / 170 | 98% | 11.69 | 450 / 459 |
| adrenal gland | 100% | 1101.83 | 258 / 258 | 97% | 11.67 | 224 / 230 |
| bladder | 100% | 744.90 | 21 / 21 | 96% | 7.03 | 482 / 504 |
| intestine | 100% | 533.09 | 964 / 966 | 95% | 5.15 | 501 / 527 |
| stomach | 100% | 451.77 | 358 / 359 | 94% | 5.21 | 270 / 286 |
| kidney | 100% | 519.06 | 89 / 89 | 93% | 6.36 | 836 / 901 |
| skin | 100% | 631.60 | 1807 / 1809 | 91% | 7.10 | 431 / 472 |
| pancreas | 87% | 195.87 | 284 / 328 | 98% | 5.82 | 174 / 178 |
| liver | 98% | 308.38 | 221 / 226 | 83% | 3.31 | 335 / 406 |
| blood vessel | 100% | 993.73 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 821.66 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 350.49 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 10.81 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.94 | 1 / 1 |
| adipose | 100% | 692.97 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 4.75 | 28 / 29 |
| heart | 96% | 624.80 | 829 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 68% | 3.76 | 54 / 80 |
| peripheral blood | 22% | 150.14 | 206 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030336 | Biological process | negative regulation of cell migration |
| GO_1902455 | Biological process | negative regulation of stem cell population maintenance |
| GO_1902459 | Biological process | positive regulation of stem cell population maintenance |
| GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0070822 | Cellular component | Sin3-type complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0042826 | Molecular function | histone deacetylase binding |
| Gene name | BRMS1L |
| Protein name | Breast cancer metastasis-suppressor 1-like protein (BRMS1-homolog protein p40) (BRMS1-like protein p40) BRMS1 like transcriptional repressor |
| Synonyms | |
| Description | FUNCTION: Involved in the histone deacetylase (HDAC1)-dependent transcriptional repression activity. When overexpressed in lung cancer cell line that lacks p53/TP53 expression, inhibits cell growth. . |
| Accessions | ENST00000547420.5 ENST00000216807.12 [Q5PSV4-1] F8VRR2 Q5PSV4 H0YHD0 ENST00000552677.5 ENST00000551774.1 |
